Found 189 matching trials
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC. PHASE2 This study is a multicenter, prospective, randomized, double-arm, Phase II ...
Show More Location
Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651
Learn More & Join Trial
Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC NA The aim of this clinical trial is to find out whether Regorafenib and Sinti...
Show More Location
The First People's Hospital of Changzhou
Learn More & Join Trial
Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcinomas PHASE1 Trial evaluating the efficacy of regorafenib combined with irinotecan compa...
Show More Location
Institut de Cancérologie de l'Ouest-Paul Papin
Learn More & Join Trial
Serplulimab+Regorafenib +Hepatic Artery Bicarbonate Infusion in Patients With Colorectal Cancer and Liver Metastases PHASE2 A single-center, single-arm, phase 2 trial of Serplulimab in combination wi...
Show More Location
the Second Affiliated Hospital of Medical College of Zhejiang University
Learn More & Join Trial
Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma PHASE2 The goal of this clinical trial is to learn if drug AST-3424 works to treat...
Show More Location
Nanjing Tianyinshan Hospital
Learn More & Join Trial
Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer PHASE2 The purpose of this study is to assess the efficacy and safety of single-ag...
Show More Location
Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Learn More & Join Trial
A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment PHASE2 This study is a multicenter, prospective, randomized controlled Phase II cl...
Show More Location
Beijing Cancer Hospital, 52 Fucheng Road
Learn More & Join Trial
STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer PHASE2 The investigators hypothesize that patients with mCRC RAS-mutant eligible f...
Show More Location
Istituto Nazionale Tumori | "Fondazione Pascale"
Learn More & Join Trial
A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) PHASE2 An open label randomised trial for adults with histologically confirmed mea...
Show More Location
Canberra Hospital
Learn More & Join Trial
Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM PHASE2 This study is a single-arm, open-label, multicenter clinical study to evalu...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial